This longitudinal study used multi-matrix metabolomics across gestational timepoints to identify whether early-to-mid pregnancy represents a critical predictive window for the later development of infantile atopic dermatitis (AD).
Metabolomic profiles collected during early-mid gestation were predictive of infantile atopic dermatitis, suggesting that this gestational window harbors key biological signals preceding AD onset in infants.
The paper abstract does not detail specific sample size, exact gestational timepoints sampled, or which biological matrices were used, limiting full appraisal of generalizability and methodology.
Clinicians and researchers should consider early-to-mid pregnancy as a key window for identifying infants at risk for atopic dermatitis; prenatal metabolomic screening may eventually inform early prevention strategies.
